The Business of Fashion
Agenda-setting intelligence, analysis and advice for the global fashion community.
Agenda-setting intelligence, analysis and advice for the global fashion community.
Puig, the Spanish conglomerate that owns brands including Charlotte Tilbury, Byredo and Paco Rabanne, is considering an initial public offering among a number of strategic options for the company to attract fresh capital while retaining control in the hands of its family owners.
An IPO “is only one of several options and no decision has been taken,” the company said in an emailed statement confirming comments by chairman Marc Puig first reported by the Financial Times.
Puig, who is a third-generation leader of the family-owned business, told the paper that an IPO would bring market discipline without forcing the family to give up their control over the business.
Rumours began to swirl in September that Puig had hired the investment banks Goldman Sachs and JPMorgan as advisers for a potential IPO, but the company declined to comment at the time.
ADVERTISEMENT
Puig is something of an anomaly by not being publicly traded: its rivals, including L’Oréal, Estée Lauder and Coty on the beauty side and LVMH and Kering on the fashion side are all market stalwarts.
The business has proven resilient to a global slowdown in luxury spending. Marc Puig told the FT that the business expects sales in excess of €4 billion ($4.2 billion) this year, ahead of its self-imposed goal of €4.5 billion by 2025.
Bankers value the business at €8-€10 billion.
Learn more:
Puig Increases Stake in Indian Beauty and Wellness Brand Kama Ayurveda
The Spanish group has increased its stake, strengthening its foothold in the fast-growing Indian beauty and personal care market.
The showcase translated the company’s global insights consumer study into scent profiles, technologies and fragrances.
The Estée Lauder-owned premium fragrance house has signed a two-year deal with the actor in a bet to seize more of the men’s market.
From medspas to telemedicine, weight loss drugs are becoming adopted for mainstream cosmetic use.
Mature consumers have long been ignored by the beauty industry. Now a small but growing number of emerging brands are responding to the needs of those over the age of 45 in a bid to cash in on their $15 trillion spending power.